Valeant Pharmaceuticals ($VRX) CEO J. Michael Pearson took a break this week from defending the company's price hike strategies to deliver good news to employees at the company's Bausch + Lomb plant in Greenville, SC. After bottle number 4 billion rolled off a contact solutions line there, Pearson told employees Valeant intends to invest up to $150 million over the next 5 years to expand capacity at the plant. He said the investments will mean as many as 200 jobs for the plant, which currently employs 500. More from FiercePharmaManufacturing